FIGURE

FIGURE 5

ID
ZDB-FIG-210708-90
Publication
Uehara et al., 2021 - Recurrent NFIA K125E substitution represents a loss-of-function allele: Sensitive in vitro and in vivo assays for nontruncating alleles
Other Figures
All Figure Page
Back to All Figure Page
FIGURE 5

HES1 and GFAP promoter assay in HEK293T cells. (a) Schematic representation of the human HES1 promoter‐NlucP and the human GFAP promoter‐NlucP constructs. Potential NFI‐binding sites (NNTTGGCNNNNNNCCNNN) predicted by TFBIND (http://tfbind.hgc.jp/; Tsunoda & Takagi, 1999) are shown by triangles. (b) HES1 promoter repression by NFIA. Dose‐dependent repression of human HES1 promoter by NFIAWT was not observed in NFIAK125E. Data are mean ± SD from triplicate experiments. **p < 0.01 by lower‐tailed Dunnett multiple comparisons test (α = 0.05). ns, not significant. (c) GFAP promoter activation by NFIA. Dose‐dependent activation of human GFAP promoter by NFIAWT was weakened in NFIAK125E. Data are mean ± SD from triplicate experiments. **p < 0.01 by upper‐tailed Dunnett multiple comparisons test (α = 0.05). ##p < 0.01 by unpaired t‐test. ns, not significant

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Am. J. Med. Genet. A